RSS Feed
My Experience with BioMime SES & MeriT-V RCT Update Ricardo Costa

My Experience with BioMime SES & MeriT-V RCT Update Ricardo Costa

Download Link
“Meril Life Sciences: Building a Global Medtech Business from India,” by David Cassak

“Meril Life Sciences: Building a Global Medtech Business from India,” by David Cassak

Article : MedTech in India—“Meril Life Sciences: Building a Global Medtech Business from India,” by David CassakRefer Link : https://www.innovationinmedtech.com/pr ... iness-india-david-cassak/
No More Absorb BVS: Abbott Puts a Stop to Sales

No More Absorb BVS: Abbott Puts a Stop to Sales

The company announced its intention to stop selling the bioresorbable scaffold in all countries but said follow-up of existing studies will continue.
World's first thin strut fully dissolvable stent developed in India

World's first thin strut fully dissolvable stent developed in India

World's first thin strut fully dissolvable stent developed in IndiaDr Ashok Seth, Chairman Fortis Escorts Heart Institute & Principal Investigator of the Study Presents Findings at Prestigious TCT Conference in Washington D.C.
The meriT-3 study

The meriT-3 study

The meriT-3 studyOne-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients
Meril’s bioresorbable, drug-eluting vascular scaffold

Meril’s bioresorbable, drug-eluting vascular scaffold

Meril Life Sciences has developed a drug-eluting, bioresorbable vascular scaffold that the body can slowly degrade and wash away.The company’s MeRes100 is made of biodegradable polymers, PLLA and PDLLA. Sirolimus, a commonly-used immunosuppressant found in drug eluting stents, is embedded in the scaffold’s coating.The company designed the struts of the device to be just 100 μm thick, while still providing the strength needed to maintain an open lumen.
« 1 (2)